Introduction
When a patient is diagnosed with cancer, one of the most important decisions they face is choosing the right treatment approach. Two of the most commonly discussed options are chemotherapy and targeted therapy. While both aim to destroy cancer cells, they work in fundamentally different ways — and the right choice depends heavily on the type of cancer, its genetic profile, and the patient's overall health.
This guide explains how each treatment works, their key differences, potential side effects, and how to decide which approach may be most appropriate for your situation.
What Is Chemotherapy?
Chemotherapy uses powerful chemical drugs to kill rapidly dividing cells throughout the body. Because cancer cells divide faster than most normal cells, chemotherapy targets them — but it also affects other fast-dividing healthy cells, such as those in the hair follicles, digestive tract, and bone marrow.
How It Works
- Drugs circulate through the bloodstream and attack all rapidly dividing cells
- Can be given intravenously (IV), orally, or by injection
- Often given in cycles with rest periods to allow the body to recover
- Can be used alone or in combination with surgery, radiation, or targeted therapy
Common Uses
- Widely applicable across many cancer types
- Used when cancer has spread (metastasized) to multiple areas
- Used before surgery (neoadjuvant) to shrink tumors, or after surgery (adjuvant) to eliminate remaining cells
- Effective even when the cancer's genetic profile is unknown
Common Side Effects
- Hair loss
- Nausea and vomiting
- Fatigue
- Increased infection risk (due to low white blood cell count)
- Mouth sores
- Peripheral neuropathy (numbness or tingling in hands and feet)
What Is Targeted Therapy?
Targeted therapy uses drugs specifically designed to identify and attack cancer cells based on specific genetic mutations or proteins that drive their growth. Unlike chemotherapy, targeted therapy is more precise — it interferes with specific molecular targets involved in cancer cell growth and survival.
How It Works
- Drugs block specific proteins, enzymes, or genetic mutations that help cancer cells grow
- Requires genetic testing (biomarker testing) to confirm the cancer has the specific target
- Can be taken orally (pills) or given intravenously
- Often used continuously rather than in cycles
Common Uses
- Lung cancer with EGFR, ALK, or ROS1 mutations
- Breast cancer with HER2 overexpression
- Chronic myeloid leukemia (CML) with BCR-ABL mutation
- Colorectal cancer with specific KRAS/BRAF mutations
- Melanoma with BRAF mutations
Common Side Effects
- Skin rash or dryness
- Diarrhea
- Liver enzyme elevation
- High blood pressure (with some agents)
- Fatigue (generally milder than chemotherapy)
- Risk of drug resistance over time
Key Differences at a Glance
| Feature | Chemotherapy | Targeted Therapy |
|---|---|---|
| Mechanism | Kills all rapidly dividing cells | Blocks specific cancer-driving molecules |
| Precision | Broad (affects healthy cells too) | High (targets specific mutations) |
| Requires genetic testing | No | Yes (biomarker testing required) |
| Administration | IV, oral, injection | Oral (pills) or IV |
| Side effect profile | Significant (hair loss, nausea, fatigue) | Generally milder, but drug-specific |
| Drug resistance | Can develop over time | More common; resistance mechanisms well-documented |
| Applicability | Most cancer types | Only cancers with specific targetable mutations |
| Cost | Varies; generally lower per cycle | Often higher; some covered by insurance |
How to Choose Between Targeted Therapy and Chemotherapy
The decision is rarely made by the patient alone — it is a collaborative process between the patient and their oncology team. Here are the key factors that guide the decision:
1. Genetic and Biomarker Testing
The first step is comprehensive genetic testing of the tumor. If a targetable mutation is identified (such as EGFR in lung cancer or HER2 in breast cancer), targeted therapy is often the preferred first-line treatment. If no actionable mutation is found, chemotherapy remains the standard approach.
2. Cancer Type and Stage
Some cancers respond exceptionally well to targeted therapy (e.g., CML, certain lung cancers), while others have no approved targeted agents and require chemotherapy. The stage of cancer also matters — advanced or metastatic cancers may require combination approaches.
3. Patient Health and Tolerance
Patients who are elderly, have compromised organ function, or cannot tolerate the side effects of chemotherapy may be better candidates for targeted therapy, which generally has a milder side effect profile.
4. Treatment Goals
Is the goal to cure, control, or palliate? Targeted therapy may offer longer progression-free survival in mutation-positive patients, while chemotherapy may be more appropriate for rapid tumor reduction before surgery.
5. Drug Resistance Planning
Targeted therapy drugs can lose effectiveness over time as cancer cells develop resistance. Oncologists often plan for second- and third-generation targeted agents or a switch to chemotherapy when resistance occurs.
6. Cost and Access
Targeted therapy drugs can be expensive. In China, many targeted agents are now covered under the National Reimbursement Drug List (NRDL), significantly reducing out-of-pocket costs. Your oncologist and our team can help clarify what is covered.
Combination Approaches
In many cases, the most effective treatment is not one or the other — it's both. Oncologists frequently combine targeted therapy with chemotherapy, immunotherapy, or radiation to improve outcomes. For example:
- HER2-positive breast cancer: targeted therapy (trastuzumab) + chemotherapy
- Lung cancer: EGFR-targeted therapy followed by chemotherapy upon resistance
- Colorectal cancer: chemotherapy backbone + targeted anti-VEGF or anti-EGFR agents
Getting Expert Cancer Care in Shanghai
Shanghai is home to some of China's leading oncology centers, including Fudan University Shanghai Cancer Center (FUSCC), Zhongshan Hospital, Ruijin Hospital, and Huashan Hospital. These institutions offer comprehensive biomarker testing, multidisciplinary tumor boards, and access to the latest targeted therapy agents — including many not yet available in other countries.
China Medical Concierge Shanghai (CMCS) specializes in helping international patients access top oncologists in Shanghai. We coordinate second opinions, genetic testing, treatment planning consultations, and ongoing care management — all with full translation and logistical support.
Contact Us
If you or a loved one is navigating a cancer diagnosis and considering treatment options in Shanghai, our team is here to help:
0 commenti